comparemela.com

Page 6 - Fresenius Vamed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fresenius : Quartalsfinanzbericht Q3 2023 (IFRS) -November 06, 2023 at 12:16 pm EST

Fresenius SE & Co KGaA (OTCMKTS:FSNUY) Short Interest Up 8 9% in October

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) saw a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 4,900 shares, a growth of 8.9% from the September 30th total of 4,500 shares. Based on an average trading volume of 66,600 shares, the […]

Financial Analysis: Fresenius SE & Co KGaA (OTCMKTS:FSNUY) vs RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY)

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) and RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation. Dividends Fresenius SE & Co. […]

Fresenius : Negative impact from a Danish pharma -October 11, 2023 at 11:04 am EDT

DCF CHANGECHANGE IN DCF€ 27.9 vs 30.5 -8.65%We have factored FMC’s weaker profitability recovery into Fresenius’ forecast period and the DCF has also been negatively impacted by the early stop.

Head to Head Analysis: Fresenius SE & Co KGaA (OTCMKTS:FSNUY) versus RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY)

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) and RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk. Earnings and Valuation This table […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.